637 related articles for article (PubMed ID: 20701288)
1. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
[TBL] [Abstract][Full Text] [Related]
2. Targeted delivery of cargoes into a murine solid tumor by a cell-penetrating peptide and cleavable poly(ethylene glycol) comodified liposomal delivery system via systemic administration.
Kuai R; Yuan W; Li W; Qin Y; Tang J; Yuan M; Fu L; Ran R; Zhang Z; He Q
Mol Pharm; 2011 Dec; 8(6):2151-61. PubMed ID: 21981683
[TBL] [Abstract][Full Text] [Related]
3. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
4. Synergistic targeted delivery of payload into tumor cells by dual-ligand liposomes co-modified with cholesterol anchored transferrin and TAT.
Tang J; Zhang L; Liu Y; Zhang Q; Qin Y; Yin Y; Yuan W; Yang Y; Xie Y; Zhang Z; He Q
Int J Pharm; 2013 Sep; 454(1):31-40. PubMed ID: 23850793
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tumor accumulation and cellular uptake of liposomes modified with ether-bond linked cholesterol derivatives.
Ran R; Zhang L; Tang J; Yin YJ; Qin Y; Liu YY; Zhang ZR; He Q
Pharmazie; 2013 Aug; 68(8):668-74. PubMed ID: 24020121
[TBL] [Abstract][Full Text] [Related]
7. [Preparation of cell penetrating peptide TAT and cleavable PEGco-modified liposomes loaded with paclitaxel and its in vitro apoptosis assay].
Fu H; Hu GL; He Q
Yao Xue Xue Bao; 2014 Jul; 49(7):1054-61. PubMed ID: 25233640
[TBL] [Abstract][Full Text] [Related]
8. A reduction-triggered delivery by a liposomal carrier possessing membrane-permeable ligands and a detachable coating.
Maeda T; Fujimoto K
Colloids Surf B Biointerfaces; 2006 Apr; 49(1):15-21. PubMed ID: 16574385
[TBL] [Abstract][Full Text] [Related]
9. Bubble liposomes and ultrasound promoted endosomal escape of TAT-PEG liposomes as gene delivery carriers.
Omata D; Negishi Y; Hagiwara S; Yamamura S; Endo-Takahashi Y; Suzuki R; Maruyama K; Nomizu M; Aramaki Y
Mol Pharm; 2011 Dec; 8(6):2416-23. PubMed ID: 22023188
[TBL] [Abstract][Full Text] [Related]
10. Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery.
Jiang T; Zhang Z; Zhang Y; Lv H; Zhou J; Li C; Hou L; Zhang Q
Biomaterials; 2012 Dec; 33(36):9246-58. PubMed ID: 23031530
[TBL] [Abstract][Full Text] [Related]
11. Liposomes co-modified with cholesterol anchored cleavable PEG and octaarginines for tumor targeted drug delivery.
Tang J; Fu H; Kuang Q; Zhang L; Zhang Q; Liu Y; Ran R; Gao H; Zhang Z; He Q
J Drug Target; 2014 May; 22(4):313-26. PubMed ID: 24404866
[TBL] [Abstract][Full Text] [Related]
12. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
[TBL] [Abstract][Full Text] [Related]
13. Lipid-polymer hybrid nanoparticles as a new generation therapeutic delivery platform: a review.
Hadinoto K; Sundaresan A; Cheow WS
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):427-43. PubMed ID: 23872180
[TBL] [Abstract][Full Text] [Related]
14. Comparison of four different peptides to enhance accumulation of liposomes into the brain.
Qin Y; Zhang Q; Chen H; Yuan W; Kuai R; Xie F; Zhang L; Wang X; Zhang Z; Liu J; He Q
J Drug Target; 2012 Apr; 20(3):235-45. PubMed ID: 22188312
[TBL] [Abstract][Full Text] [Related]
15. Reduction-triggered delivery using nucleoside-lipid based carriers possessing a cleavable PEG coating.
Oumzil K; Khiati S; Grinstaff MW; Barthélémy P
J Control Release; 2011 Apr; 151(2):123-30. PubMed ID: 21354443
[TBL] [Abstract][Full Text] [Related]
16. Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles.
Kanazawa T; Sugawara K; Tanaka K; Horiuchi S; Takashima Y; Okada H
Eur J Pharm Biopharm; 2012 Aug; 81(3):470-7. PubMed ID: 22579732
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid.
Hatakeyama H; Akita H; Kogure K; Oishi M; Nagasaki Y; Kihira Y; Ueno M; Kobayashi H; Kikuchi H; Harashima H
Gene Ther; 2007 Jan; 14(1):68-77. PubMed ID: 16915290
[TBL] [Abstract][Full Text] [Related]
18. Increased delivery of doxorubicin into tumor cells using extracellularly activated TAT functionalized liposomes: in vitro and in vivo study.
Yuan W; Kuai R; Ran R; Fu L; Yang Y; Qin Y; Liu Y; Tang J; Fu H; Zhang Q; Yuan M; Zhang Z; Gao F; He Q
J Biomed Nanotechnol; 2014 Aug; 10(8):1563-73. PubMed ID: 25016656
[TBL] [Abstract][Full Text] [Related]
19. A new peptide motif present in the protective antigen of anthrax toxin exerts its efficiency on the cellular uptake of liposomes and applications for a dual-ligand system.
Kibria G; Hatakeyama H; Harashima H
Int J Pharm; 2011 Jun; 412(1-2):106-14. PubMed ID: 21414394
[TBL] [Abstract][Full Text] [Related]
20. Novel PEG-matrix metalloproteinase-2 cleavable peptide-lipid containing galactosylated liposomes for hepatocellular carcinoma-selective targeting.
Terada T; Iwai M; Kawakami S; Yamashita F; Hashida M
J Control Release; 2006 Apr; 111(3):333-42. PubMed ID: 16488046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
